Quadratus Lumborum Block vs Intrathecal Morphine for Post-Cesarean Analgesia
Comparison of Postoperative Analgesic Efficacy of Quadratus Lumborum Block and Intrathecal Morphine Administration in Cesarean Deliveries
1 other identifier
interventional
118
1 country
1
Brief Summary
İn this study, planned to compare the post-operative analgesic efficacy of Intrathecal Morphine Administration and anterior Quadratus lumborum Block in elective cesarean section operations. this study primary aim is; To compare the amount of total analgesic use in the first 24 hours in patients Our secondary aims are: 1.) To compare and evaluate the first rescue analgesia requirement times 2.) To compare the NRS (Numering rating scale) values (resting and dynamic) at 2. 4. 8. 12 . 24. hours in the postoperative follow-up of the patients after anterior Quadratus lumborum block and Intrathecal morphine administration for postoperative analgesia after elective cesarean section operations under spinal anesthesia. 3.) Comparing the side effects such as postoperative nausea and vomiting
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable postoperative-pain
Started Sep 2024
Shorter than P25 for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2024
CompletedStudy Start
First participant enrolled
September 22, 2024
CompletedFirst Posted
Study publicly available on registry
September 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedFebruary 5, 2026
May 1, 2025
6 months
September 21, 2024
February 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
comparing the amount of total analgesic use in the first 24 hours in patients
For all Participants, postoperative analgesia was planned as paracetamol 1g four times a day for the first 24 hours after surgery. Participants with Numeric Rating Scale (NRS) scores greater than 3 at 2, 4, 8, 12, and 24 hours postoperatively will receive rescue analgesia with diclofenac sodium 75 mg at a dose intravenos.The total diklofenac sodium consumption of participants within the first 24 hours will be compared. (At initial trial registration, postoperative NRS pain scores were specified as the primary outcome. During the study phase, total postoperative analgesic consumption was used as the primary outcome for statistical planning, analysis, and reporting. The trial registration was updated to ensure consistency between registered outcomes and analyses. NRS pain scores were analyzed as secondary outcomes. This update was not based on study results.)
24 hour
Secondary Outcomes (3)
To compare the NRS (Numering rating scale) values (resting and dynamic) at 2. 4. 8. 12 . 24. hours in the postoperative follow-up of the patients
24 hour
To compare postoperative side effects such as nausea, vomiting, and itching.
24 hour
time to first rescue analgesic requirement.
24 hour
Study Arms (3)
anterior quadratus lumborum block
ACTIVE COMPARATORAll blocks will be performed by the same anesthesiologist using ultrasound guidance. In the Quadratus Lumborum block group, patients will be placed in the lateral decubitus position. A convex ultrasound probe will be placed in sterile conditions along the midaxillary line, in the subcostal area above the iliac crest, to visualize the quadratus lumborum and psoas major muscles, as well as the L4 vertebral transverse process. Using an in-plane technique, a 22G, 100 mm peripheral block needle will be advanced anterior to the quadratus lumborum muscle and into the subfascial space between the quadratus lumborum and psoas major muscles. After confirming the correct location with hydrodissection, 20 mL of 0.25% bupivacaine will be injected slowly, observing the fascial displacement on ultrasound. The same procedure will be repeated on the contralateral side.
intratechal morphine group
ACTIVE COMPARATORIn the intrathecal morphine group, 100 micrograms of morphine (0.1 mL) will be added to the 12 mg of intrathecally administered bupivacaine.
control group
NO INTERVENTIONParticipants in the control group will not receive any interventions such as intrathecal morphine or quadratus lumborum block. They will undergo cesarean sections under spinal anesthesia.
Interventions
In the Quadratus Lumborum block group, Participants will be placed in the lateral decubitus position. A convex ultrasound probe will be placed in sterile conditions along the midaxillary line, in the subcostal area above the iliac crest, to visualize the quadratus lumborum and psoas major muscles, as well as the L4 vertebral transverse process. Using an in-plane technique, a 22G, 100 mm peripheral block needle will be advanced anterior to the quadratus lumborum muscle and into the subfascial space between the quadratus lumborum and psoas major muscles. After confirming the correct location with hydrodissection, 20 mL of 0.25% bupivacaine will be injected slowly, observing the fascial displacement on ultrasound. The same procedure will be repeated on the contralateral side.
In the intrathecal morphine group, 100 micrograms of morphine (0.1 mL) will be added to the 12 mg of intrathecally administered bupivacaine.
Eligibility Criteria
You may qualify if:
- Participants aged between 18 and 40
- ASA 2 risk group
- Participants at 37-41 weeks of pregnancy
- undergoing cesarean section under spinal anesthesia
You may not qualify if:
- The participant does not accept the procedure.
- Patients with a history of eclampsia and preeclampsia during pregnancy
- local anesthetic allergy
- Infection at the procedure site
- Anticoagulant use with bleeding disorder
- Chronic analgesia and opioid use
- Mental, psychiatric and neurological problems -Participant with ASA 3 and above with a history of any chronic disease. -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziosmanpasa Research and Education Hospital, Istanbul, 34000
Istanbul, 34255, Turkey (Türkiye)
Related Publications (2)
Sharpe EE, Molitor RJ, Arendt KW, Torbenson VE, Olsen DA, Johnson RL, Schroeder DR, Jacob AK, Niesen AD, Sviggum HP. Intrathecal Morphine versus Intrathecal Hydromorphone for Analgesia after Cesarean Delivery: A Randomized Clinical Trial. Anesthesiology. 2020 Jun;132(6):1382-1391. doi: 10.1097/ALN.0000000000003283.
PMID: 32251031RESULTHussain N, Brull R, Weaver T, Zhou M, Essandoh M, Abdallah FW. Postoperative Analgesic Effectiveness of Quadratus Lumborum Block for Cesarean Delivery under Spinal Anesthesia. Anesthesiology. 2021 Jan 1;134(1):72-87. doi: 10.1097/ALN.0000000000003611.
PMID: 33206131RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Serpil Sehirlioglu
Gaziosmanpasa Research and Education Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
September 21, 2024
First Posted
September 25, 2024
Study Start
September 22, 2024
Primary Completion
March 28, 2025
Study Completion
April 1, 2025
Last Updated
February 5, 2026
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
If requested, it can be provided by contacting the corresponding author.